Search

Your search keyword '"Willems, Stefan M."' showing total 191 results

Search Constraints

Start Over You searched for: Author "Willems, Stefan M." Remove constraint Author: "Willems, Stefan M." Database Unpaywall Remove constraint Database: Unpaywall
191 results on '"Willems, Stefan M."'

Search Results

1. Improved delineation with diffusion weighted imaging for laryngeal and hypopharyngeal tumors validated with pathology

5. Improved Delineation with Diffusion Weighted Imaging for Laryngeal and Hypopharyngeal Tumors Validated with Pathology

8. Author Correction: Accurate detection of circulating tumor DNA using nanopore consensus sequencing

9. Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification

10. Data from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

11. Movie S1 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

12. Movie S3 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

13. Movie S5 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

14. Movie S4 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

15. Movie S2 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

16. Supplementary Data from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

17. Supplementary Data from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

18. Movie S2 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

19. Supplementary Data from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

20. Movie S1 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

21. Movie S3 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

22. Supplementary Data from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

23. Movie S4 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

24. Supplementary Data from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

25. Movie S5 from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

26. Data from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

27. Supplementary Data from Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

29. Supplementary Figure S1. FGFR1 protein expression and FGFR1 gene copy-numbers in HPV-positive and HPV-negative head and neck squamous cell carcinoma. from FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma

30. Supplementary Table S1. Results of FGFR1 protein expression and FGFR1 gene copy-numbers in HPV-positive and HPV-negative head and neck squamous cell carcinoma. from FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma

35. Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy

36. Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non–Small-Cell Lung Cancer in the Netherlands

40. Assessing the prognostic value of tumor-infiltrating CD57+ cells in advanced stage head and neck cancer using QuPath digital image analysis

41. Response to “Head and neck cancer diagnoses and faster treatment initiation during COVID-19: Correspondence”

44. Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era

45. Fewer head and neck cancer diagnoses and faster treatment initiation during COVID-19 in 2020: A nationwide population-based analysis

47. Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma

48. Accurate detection of circulating tumor DNA using nanopore consensus sequencing

49. De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?

Catalog

Books, media, physical & digital resources